VAV2 Drives EGFR-Mediated Rac1 Responses in Prostate Cancer
This study highlights the central role of VAV2 in prostate cancer cell proliferation and migration, as well as its potential prognostic value in disease progression.
Authors
- Cornelis P. Vlaar (ORCID: https://orcid.org/0000-0001-5145-8300)
- Suranganie Dharmawardhane (ORCID: https://orcid.org/0000-0001-7127-1180)
- Marcelo G. Kazanietz (ORCID: https://orcid.org/0000-0001-8779-017X)
- Priti Lal (ORCID: https://orcid.org/0000-0002-5839-8205)
- Mariana Cooke (ORCID: https://orcid.org/0000-0001-9300-8447)
- Martı́n C. Abba (ORCID: https://orcid.org/0000-0002-9206-2369)
- Martin J. Baker (ORCID: https://orcid.org/0000-0002-9743-6294)
- Suli Zhang (ORCID: https://orcid.org/0000-0003-4894-1160)
- Daniel Zhang (ORCID: https://orcid.org/0000-0002-7975-1653)
- Joshua Searle (ORCID: https://orcid.org/0000-0002-1055-0247)
Institutions
- University of Miami (US)
- University of Puerto Rico, Medical Sciences Campus (PR)
- Hospital of the University of Pennsylvania (US)
- University of Manchester (GB)
- Cancer Research UK Manchester Institute (GB)
- University of Pennsylvania (US)
- Universidad Nacional de La Plata (AR)
Publication Details
- Journal
- Molecular Cancer Research
- Published
- 2025-04-04
- DOI
- https://doi.org/10.1158/1541-7786.mcr-24-0957
- Citations
- 1
- Primary Topic
- Hippo pathway signaling and YAP/TAZ
- Type
- article
- Field-Weighted Citation Impact
- 1.15